# [Project Name] - Needs Analysis Report

**Comprehensive Market Validation & Strategic Roadmap**

---

**Prepared for:** [Client Name]
**Date:** [YYYY-MM-DD]
**Framework:** Vianeo Business Validation Methodology

---

## SECTION 1: EXECUTIVE SUMMARY

### Three-Act Structure

**Act I: Where We Are Now** ‚Äî [Describe what's been validated: technical efficacy, segments, metrics, partnerships. Include specific numbers. 3-4 lines.]

**Act II: What's Missing** ‚Äî [Describe unvalidated segments with revenue impact, critical gaps that block progress, quality/pricing validation needs. Include specific numbers and percentages. 3-4 lines.]

**Act III: What We Recommend** ‚Äî [Describe specific action needed: 30-day sprint with specific targets, conversion goals (e.g., 40% beta to paid), quality thresholds (e.g., 7+ rating from professionals). 3-4 lines.]

---

### üí° VALIDATION SNAPSHOT

**Product Efficacy (Proven):**
- [Metric 1 with specific number - e.g., "60% time reduction measured with 30+ users"]
- [Metric 2 with specific number - e.g., "30% quality improvement documented"]
- [Metric 3 with specific number - e.g., "$25K pilot contract signed"]

**Critical Gaps:**
- ‚ö† [Gap 1 - e.g., "Zero revenue validated"] ‚Üê HIGHLIGHT IN YELLOW
- ‚ö† [Gap 2 - e.g., "Four institutional segments (40% revenue) uninterviewed"]
- ‚ö† [Gap 3 - e.g., "Quality threshold validation incomplete"]

---

### Current State Assessment

| Dimension | Current State | Status |
|-----------|--------------|--------|
| **Product** | [Description of validated efficacy - e.g., "60% time reduction, 30% quality improvement with 50+ beta users"] | ‚ö† **Partial** |
| **Beachhead** | [Description of initial segment validation - e.g., "50+ active beta users, 2 partnerships established"] | ‚úÖ **Validated** |
| **Institutional** | [Description of institutional validation - e.g., "Zero interviews, zero revenue data from universities/accelerators"] | ‚ùå **Not Tested** |

**Legend:** ‚úÖ Validated | ‚ö† Partial | ‚ùå Not Tested

---

### Decision Ask

[1-2 paragraphs stating what decision is required. Include:]
- What decision needs to be made
- Budget allocation ($X-Y, representing X% of funding)
- Who owns the decision (CEO, Product Lead, specific role)
- Conditions that must be met before proceeding

**Example:** "Approve 30-day validation sprint with $15K-20K budget (15-20% of seed funding). CEO assigns Biz Dev Lead to complete 15-20 institutional buyer interviews. Product Lead validates quality threshold (7+ rating from 5+ external reviewers). Gate MVP commitment on achieving: (1) 40% beta conversion, (2) institutional buyer validation, (3) professional quality certification."

---

### ‚ö† CRITICAL DECISION POINT

**What's Validated:**
- [What has been proven - e.g., "Product works: 60% faster, 30% better, $25K pilot contract"]
- [What segments are validated - e.g., "Beachhead segment: 50+ active users, strong engagement"]

**What's Missing:**
- [What hasn't been tested - e.g., "Institutional segments: 60-80% of revenue potential, zero interviews"]
- [What validation is needed - e.g., "Revenue model: Zero paying customers, pricing untested"]

**Revenue Impact:** [Percentage] of total revenue potential remains unvalidated

**Risk:** Proceeding without institutional validation = building for wrong buyer, wrong pricing model, wrong feature set

**Recommendation:** Execute 30-day validation sprint. [Specific targets: interviews, conversion %, quality rating]. Do not commit to MVP build until gates passed.

---

## SECTION 2: CUSTOMER SEGMENT NEEDS MATRIX

### Validation Status by Segment

#### ‚úÖ PROVEN (Revenue Level: $X-Y/month or $XK-YK/year)

| [Segment Name 1] | [Segment Name 2] | [Segment Name 3] |

**Owner:** [Role - e.g., Product Lead]
**Action:** [What to do - e.g., "Convert to paid, gather testimonials, build case studies"]

---

#### ‚è≥ HYPOTHESIS ONLY (Revenue Level: $X-Y/month or $XK-YK/year)

| [Segment Name 4] | [Segment Name 5] | [Segment Name 6] |

**Owner:** [Role - e.g., Biz Dev Lead]
**Action:** [What to do in Week X-Y - e.g., "Week 1-2: Complete 15-20 interviews, validate buying process and pricing"]

---

#### ‚è∏ DEFERRED (Timeframe: 6-12 months)

| [Segment Name 7] | [Segment Name 8] |

**Rationale:** [Why deferred - e.g., "Long sales cycles (18+ months), requires partnerships with [X], prioritize after beachhead secured"]

---

### Key Insight

[2-3 sentences stating the gap between where validation exists and where revenue potential is highest]

**Example:** "Strongest validation aligns with lower revenue segments (consultants, startups: $X-Y/month). Highest revenue opportunities (universities, accelerators, foundations: $XK-YK/year, 60-80% of total) remain untested. Sprint must move these from hypothesis to validation before MVP commitment."

---

## SECTION 3: MARKET LANDSCAPE & OPPORTUNITY

### Problem Definition

| Pain Point | Impact & Market Size |
|------------|---------------------|
| **[Pain 1 Name]** | [Quantified impact - e.g., "15-40 hours per grant application, 200+ hours/year for active grant seekers"] |
| **[Pain 2 Name]** | [Quantified impact - e.g., "30-40% rejection rate due to compliance errors, $X lost opportunity cost"] |
| **[Pain 3 Name]** | [Quantified impact - e.g., "$X-Y cost for consultant services, prohibitive for small organizations"] |
| **[Pain 4 Name]** | [Quantified impact - e.g., "X% of [segment] lack access to expert grant writers"] |
| **Market Size** | **TAM: $XM, SAM: $XM, SOM: $XM** (Detail methodology in footnote) |

*Last row (Market Size) should have light blue background*

---

### Competitive Positioning

**[White space description]:** No competitor combines [key differentiator 1], [key differentiator 2], and [key differentiator 3] in a single workflow optimized for [target user].

| Competitor | Limitations | [Client Name]'s Advantage |
|------------|-------------|---------------------------|
| **Generic AI** (ChatGPT, Claude)<br>$20-200/mo | ‚Ä¢ [Limitation 1]<br>‚Ä¢ [Limitation 2]<br>‚Ä¢ [Limitation 3] | **[Your advantage]** [Specific differentiator with evidence] |
| **[Direct Competitor 1]**<br>$X-Y/mo | ‚Ä¢ [Limitation 1]<br>‚Ä¢ [Limitation 2]<br>‚Ä¢ [Limitation 3] | **[Your advantage]** [Specific differentiator with evidence] |
| **[Vertical SaaS]**<br>$X-Y/mo | ‚Ä¢ [Limitation 1]<br>‚Ä¢ [Limitation 2]<br>‚Ä¢ [Limitation 3] | **[Your advantage]** [Specific differentiator with evidence] |
| **Human Services**<br>$X-Y per project | ‚Ä¢ [Limitation 1]<br>‚Ä¢ [Limitation 2]<br>‚Ä¢ [Limitation 3] | **[Your advantage]** [Specific differentiator with evidence] |

*Client advantage column should have light blue background*

---

### üí° KEY INSIGHT: [Title of Strategic Insight]

[First sentence: State the insight clearly]

[Second sentence: Provide evidence that validates this insight]

[Third sentence: Explain how this insight creates opportunity or addresses a major pain point]

**Example:** "Partner channel sees AI as assistant, not replacement. 8 interviews with consultants show willingness to integrate tools that enhance (not replace) their expertise, with 3 requesting pilot access. This positions [Product] as channel amplifier rather than competitor, enabling B2B2C distribution strategy."

---

## SECTION 4: SEGMENT VALIDATION & PRIORITIES

### Full Segment Assessment

| Segment | Status | Evidence | Revenue | 30-Day Priority |
|---------|--------|----------|---------|----------------|
| [Segment 1] | ‚úÖ **PROVEN** | [Evidence - e.g., "30+ active users, 5-month average engagement, 2 partnerships established"] | $X-Y/mo | **Critical:** Convert to paid, gather testimonials |
| [Segment 2] | ‚úÖ **PROVEN** | [Evidence] | $X-Y/mo | **Critical:** Convert to paid, gather testimonials |
| [Segment 3] | ‚è≥ **NOT TESTED** | <span style="color: red;">Zero data</span> | $XK-YK/yr | **High:** 10+ interviews in Week 1-2 |
| [Segment 4] | ‚è≥ **NOT TESTED** | <span style="color: red;">Zero data</span> | $XK-YK/yr | **High:** 10+ interviews in Week 1-2 |
| [Segment 5] | ‚è≥ **NOT TESTED** | <span style="color: red;">Zero data</span> | $XK-YK/yr | **High:** 5+ interviews in Week 1-2 |
| [Segment 6] | ‚úÖ **PROVEN** | [Evidence] | $X-Y/mo | **Monitor:** Track engagement, prepare for scaling |
| [Segment 7] | ‚è∏ **DEFERRED** | [Rationale for deferral] | $XK-YK/yr | **Defer:** Not in scope for 6-12 months |

**Order:** All validated segments first (alphabetically), then unvalidated by revenue potential (highest first)

---

### ‚ö† STRATEGIC IMPERATIVE

**Institutional Segment Validation Required:**

[X number] institutional segments representing [X]% of total revenue potential remain completely unvalidated:
- [Segment A]: $XK-YK/year potential
- [Segment B]: $XK-YK/year potential
- [Segment C]: $XK-YK/year potential

**Required Action:** 15-20 interviews per segment in Week 1-2 of sprint

**Must Test:**
- Procurement processes and approval hierarchies
- Compliance and integration requirements
- Pricing and budget allocation processes
- Decision stakeholder maps
- Annual planning cycles and timing

**Consequence:** Without this validation, risk building wrong product for wrong buyer at wrong price point. [X]% of revenue plan unverifiable.

---

## SECTION 5: RISK ASSESSMENT

### Critical Risks

| Risk | Impact | Mitigation (30-Day Sprint) |
|------|--------|---------------------------|
| **Quality Threshold Risk**<br><span style="color: #DC3545;">**(CRITICAL)**</span><br>[Brief description of risk - e.g., "AI-generated outputs don't meet professional standards for grant submission"] | ‚Ä¢ Destroys credibility with institutional buyers<br>‚Ä¢ Negative word-of-mouth in tight communities<br>‚Ä¢ Rejection by compliance officers | **Blind A/B testing:** 5+ professionals rate outputs vs. human baseline. **Target:** 7+ rating (1-10 scale). **Quality benchmarking:** Test against funded grants. **Gate:** No MVP launch until threshold met. |
| **[Risk 2 Name]**<br><span style="color: #DC3545;">**(CRITICAL/HIGH)**</span><br>[Description] | ‚Ä¢ [Impact 1]<br>‚Ä¢ [Impact 2]<br>‚Ä¢ [Impact 3] | **[Mitigation action 1]** [Details]. **[Mitigation action 2]** [Details]. **Gate:** [Specific threshold]. |
| **[Risk 3 Name]**<br><span style="color: #DC3545;">**(HIGH/MEDIUM)**</span><br>[Description] | ‚Ä¢ [Impact 1]<br>‚Ä¢ [Impact 2] | **[Mitigation action]** [Details]. **Gate:** [Specific threshold]. |

*First row should have light red background (#F8D7DA)*

---

### Red Flags (5-7 Specific Conditions)

Watch for these signals during validation sprint:

- **[Metric/threshold] ‚Üí [Consequence] ‚Üí [Action]**
  Example: "Less than 20% beta conversion after pricing launch ‚Üí willingness to pay unproven ‚Üí pause MVP, reassess value prop"

- **[Metric/threshold] ‚Üí [Consequence] ‚Üí [Action]**
  Example: "18+ month sales cycles in enterprise interviews ‚Üí market not ready ‚Üí pivot to SMB beachhead first"

- **[Metric/threshold] ‚Üí [Consequence] ‚Üí [Action]**
  Example: "Any compliance hallucination causing grant disqualification ‚Üí quality threshold not met ‚Üí do not launch"

- **[Metric/threshold] ‚Üí [Consequence] ‚Üí [Action]**
  Example: "3+ consultants see as competitive threat ‚Üí channel conflict risk ‚Üí reposition as white-label tool"

- **[Metric/threshold] ‚Üí [Consequence] ‚Üí [Action]**

- **[Metric/threshold] ‚Üí [Consequence] ‚Üí [Action]**

- **[Metric/threshold] ‚Üí [Consequence] ‚Üí [Action]**

---

## SECTION 6: DECISION FRAMEWORK

### Current State: What We Know vs. What We Don't

#### ‚úÖ VALIDATED | ‚ö† MISSING

**‚úÖ VALIDATED**
- [What's proven - e.g., "Product efficacy: 60% time reduction measured with 30+ users"]
- [What's proven - e.g., "Quality improvement: 30% better outputs documented"]
- [What's proven - e.g., "Beachhead engagement: 50+ active beta users, 5-month avg."]
- [What's proven - e.g., "Partnership validation: 2 signed partners, 1 pilot contract ($25K)"]

**‚ö† MISSING**
- [What's missing - e.g., "Revenue: Zero paying customers, pricing completely untested"]
- [What's missing - e.g., "Institutional buyers: 60-80% revenue potential, zero interviews"]
- [What's missing - e.g., "Quality threshold: No external professional validation (blind testing)"]
- [What's missing - e.g., "Compliance: No disqualification testing with real submission processes"]

---

### The Choice

| Option A: [Action] Now | Option B: [Action] First ‚úì |
|------------------------|----------------------------|
| **PROS:**<br>‚Ä¢ [Pro 1]<br>‚Ä¢ [Pro 2]<br>‚Ä¢ [Pro 3] | **PROS:**<br>‚Ä¢ [Pro 1]<br>‚Ä¢ [Pro 2]<br>‚Ä¢ [Pro 3]<br>‚Ä¢ [Pro 4] |
| **RISKS:**<br>‚Ä¢ [Risk 1]<br>‚Ä¢ [Risk 2]<br>‚Ä¢ [Risk 3] | **RISKS:**<br>‚Ä¢ [Risk 1]<br>‚Ä¢ [Risk 2] |
| **TIMELINE:** [X days/weeks] | **TIMELINE:** [X days/weeks] |

*Option B (recommended) column should have light blue background, blue text header, and checkmark ‚úì*

---

### üí° RECOMMENDED PATH

**Option B with [specific approach - e.g., "dual-track validation sprint"]**

How it works: [One sentence explaining the approach - e.g., "Run institutional interviews (Week 1-2) in parallel with beta conversion push (Week 3-4) while conducting ongoing quality validation throughout."]

**What this validates:**
1. [Validation target 1 - e.g., "Pricing & willingness to pay: 40% beta conversion to paid"]
2. [Validation target 2 - e.g., "Institutional buyer process: 15-20 interviews across 3 segments"]
3. [Validation target 3 - e.g., "Quality threshold: 7+ rating from 5+ professionals"]
4. [Validation target 4 - e.g., "Product-market fit signals: NPS, engagement, referrals"]

---

## SECTION 7: 30-DAY ACTION PLAN

### Execution Timeline

| Timeframe | Activities | Output |
|-----------|-----------|--------|
| **Week 1-2: Institutional Research** | ‚Ä¢ [Activity 1 with specific number - e.g., "5 university research office interviews"]<br>‚Ä¢ [Activity 2 - e.g., "5 accelerator program director interviews"]<br>‚Ä¢ [Activity 3 - e.g., "5 foundation program officer interviews"]<br>‚Ä¢ [Activity 4 - e.g., "Document: procurement, compliance, pricing, integrations"]<br>‚Ä¢ [Activity 5 - e.g., "Build stakeholder maps and buying motion documentation"] | **Institutional Buyer Playbook**<br>with validated pricing model and buying process for each segment |
| **Week 3-4: Beta Conversion** | ‚Ä¢ [Activity 1 - e.g., "Launch pricing to 50+ beta users"]<br>‚Ä¢ [Activity 2 - e.g., "Target: 20+ paid customers (40% conversion)"]<br>‚Ä¢ [Activity 3 - e.g., "Document objections and pricing feedback"]<br>‚Ä¢ [Activity 4 - e.g., "Build 3-5 customer case studies"]<br>‚Ä¢ [Activity 5 - e.g., "Track: NPS, engagement changes, churn signals"] | **Validated Pricing Strategy**<br>with revenue data, objection handling, and conversion case studies |
| **Ongoing: Quality Validation** | ‚Ä¢ [Activity 1 - e.g., "Blind testing: 5+ professionals rate AI outputs vs. human baseline"]<br>‚Ä¢ [Activity 2 - e.g., "Competitive comparison: outputs vs. funded grants"]<br>‚Ä¢ [Activity 3 - e.g., "Track success rates and quality scores"]<br>‚Ä¢ [Activity 4 - e.g., "Compliance checking: test for hallucinations and errors"] | **Quality Certification**<br>7+ rating achieved, documented comparison results, compliance testing complete |

*Output column should have light blue background*

---

### Budget Allocation

**Budget Allocation ($15K-20K):** Interview compensation ($1,500-2,000 for 15-20 interviews at $50-100 each), Competitive subscriptions ($500-800 for testing 4-6 tools), Blind testing compensation ($1,000-1,500 for professional reviewers), User researcher/consultant ($5K-8K if outsourced, $0 if in-house capability), Advisory board stipends ($2K-5K for 2-3 advisors providing buyer introductions and validation)

---

### Decision Gates

| Gate | Current | Target | Owner | Deadline |
|------|---------|--------|-------|----------|
| **Beta Engagement** | ‚úÖ **50+ users** | 50+ active users | Product Lead | **ACHIEVED** |
| **Efficacy Metrics** | ‚úÖ **60% faster, 30% better** | Time reduction + quality improvement | Product Lead | **ACHIEVED** |
| **Quality Validation** | ‚è≥ **Testing** | 7+ rating from 5+ professionals | Product Lead | **Sprint End** |
| **Pricing Validation** | ‚ùå **0% paid** | 40% beta conversion (20+ customers) | CEO/GTM | **Week 3-4** |
| **B2B Segment Validation** | ‚ùå **0 interviews** | 15-20 institutional interviews | Biz Dev Lead | **Week 1-2** |
| **Compliance Validation** | ‚è≥ **Testing** | 0 disqualifications in real process | Product Lead | **Ongoing** |

**Legend:** ‚úÖ Achieved | ‚è≥ In Progress/Testing | ‚ùå Not Started

---

### ‚úì SUCCESS CRITERIA ‚Üí PROCEED TO MVP

If 30-day sprint achieves ALL of the following, proceed with MVP build commitment:

‚Ä¢ **15+ institutional interviews completed** across universities, accelerators, foundations with documented buying process and pricing validation

‚Ä¢ **40% beta conversion (20+ paying customers)** demonstrating validated willingness to pay and revenue model viability

‚Ä¢ **10+ funded grants/outcomes tracked** proving product enables real-world success in target use cases

‚Ä¢ **7+ professional quality rating** from 5+ external reviewers in blind A/B testing vs. human baseline outputs

‚Ä¢ **1+ institutional partnership/contract signed** validating B2B buyer interest and sales cycle feasibility

<span style="color: #DC3545; font-weight: bold;">IF THRESHOLDS MISSED ‚Üí REASSESS PRODUCT-MARKET FIT. Do not proceed with major build investment until gaps addressed.</span>

---

## SECTION 8: VALIDATION STATUS DASHBOARD

### Segment Status & Ownership

---

#### ‚úÖ PROVEN (Ongoing Engagement)

**[Segment 1]** | **[Segment 2]** | **[Segment 3]**

**Owner:** [Role - e.g., Product Lead]
**Action:** [What to do - e.g., "Convert to paid subscriptions, gather case studies and testimonials, track engagement metrics"]

---

#### ‚è≥ NOT TESTED (Sprint Priority)

**[Segment 4]** | **[Segment 5]** | **[Segment 6]**

**Owner:** [Role - e.g., Biz Dev Lead]
**Action:** [What to do with timeframe - e.g., "Week 1-2: Complete 15-20 interviews testing procurement, compliance, pricing, integrations, and decision hierarchies"]

---

#### ‚è∏ DEFERRED (6-12 Months)

**[Segment 7]** | **[Segment 8]**

**Rationale:** [Why deferred - e.g., "18+ month sales cycles require established case studies and institutional references. Prioritize after beachhead secured and initial institutional partnerships proven."]

---

### üö® FINAL DECISION RULE

**Do not lock MVP scope or major build budget until:**

1. **15-20 institutional buyer interviews completed** validating procurement, pricing, compliance, and buying process across universities, accelerators, and foundations, AND

2. **Quality threshold (7+ rating)** + **Pricing validation (40% conversion)** gates passed

If any gate fails: reassess product-market fit assumptions before proceeding. If any red flag triggers (18+ month cycles, <20% conversion, compliance hallucinations, channel conflict): pivot strategy immediately.

**Consequence of Proceeding Without Validation:** Risk building $X00K MVP for wrong buyer at wrong price with wrong features, discovering gaps only after significant capital spent.

---

## FOOTER

---

**Vianeo Needs Qualification Validation Framework**

**Data Sources:** [Source 1 - e.g., "Step 5 Desirability Analysis"] | [Source 2 - e.g., "50+ beta user interviews"] | [Source 3 - e.g., "Competitive testing of 6 alternatives"] | [Source 4 - e.g., "Partnership discussions with 8 organizations"]

**Status:** <span style="color: #28A745;">**3 segments validated**</span> | <span style="color: #FF6B35;">**4 segments require research**</span> | <span style="color: #DC3545;">**0 paying customers**</span>

---

*[Company Name] | Vianeo Needs Qualification Validation | Page X of Y*
